Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Recruiting 4Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4CNS 4

Conditions

Melanoma 8Colorectal Neoplasms 7Brain Neoplasms 4Colonic Neoplasms 2Solid Tumors 1Leukemia, Hairy Cell 1Biliary Tract Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23Radiosurgery 21Temozolomide 14Bevacizumab 11pembrolizumab 10Specimen Handling 9Nivolumab 8Radiotherapy 7Ipilimumab 7Magnetic Resonance Imaging 6Cyclophosphamide 5Capecitabine 5Blood Specimen Collection 5encorafenib 4Radiation 4Neuropsychological Tests 4Mental Status and Dementia Tests 4Memantine 4Carboplatin 4fludarabine 3fluciclovine F-18 3binimetinib 3abemaciclib 3Watchful Waiting 3Proton Therapy 3Etoposide 3Dexamethasone 3Adrenal Cortex Hormones 3trastuzumab deruxtecan 2sacituzumab govitecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Brain Neoplasms × encorafenib × Clear all
NCT06194929 2025-12-03

DETERMINE

University of Utah

Phase 1/2 Recruiting
33 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT06887088 2025-10-01

ENCEFALO

Grupo Español Multidisciplinar de Melanoma

Phase 2 Recruiting
33 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT04511013 2025-09-11

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

SWOG Cancer Research Network

Phase 2 Recruiting
112 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT03563729 2023-07-13

MEMBRAINS

Herlev Hospital

Phase 2 Recruiting
80 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡